1. Home
  2. BCAB vs HMNF Comparison

BCAB vs HMNF Comparison

Compare BCAB & HMNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • HMNF
  • Stock Information
  • Founded
  • BCAB 2007
  • HMNF 1934
  • Country
  • BCAB United States
  • HMNF United States
  • Employees
  • BCAB N/A
  • HMNF N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • HMNF Savings Institutions
  • Sector
  • BCAB Health Care
  • HMNF Finance
  • Exchange
  • BCAB Nasdaq
  • HMNF Nasdaq
  • Market Cap
  • BCAB 91.4M
  • HMNF 119.4M
  • IPO Year
  • BCAB 2020
  • HMNF 1994
  • Fundamental
  • Price
  • BCAB $1.74
  • HMNF $25.50
  • Analyst Decision
  • BCAB Strong Buy
  • HMNF
  • Analyst Count
  • BCAB 3
  • HMNF 0
  • Target Price
  • BCAB $8.67
  • HMNF N/A
  • AVG Volume (30 Days)
  • BCAB 1.0M
  • HMNF 4.7K
  • Earning Date
  • BCAB 08-08-2024
  • HMNF 10-17-2024
  • Dividend Yield
  • BCAB N/A
  • HMNF 1.57%
  • EPS Growth
  • BCAB N/A
  • HMNF N/A
  • EPS
  • BCAB N/A
  • HMNF 1.19
  • Revenue
  • BCAB N/A
  • HMNF $38,260,000.00
  • Revenue This Year
  • BCAB N/A
  • HMNF N/A
  • Revenue Next Year
  • BCAB N/A
  • HMNF N/A
  • P/E Ratio
  • BCAB N/A
  • HMNF $21.43
  • Revenue Growth
  • BCAB N/A
  • HMNF N/A
  • 52 Week Low
  • BCAB $1.14
  • HMNF $17.60
  • 52 Week High
  • BCAB $4.02
  • HMNF $27.06
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 49.35
  • HMNF 47.16
  • Support Level
  • BCAB $1.72
  • HMNF $25.71
  • Resistance Level
  • BCAB $1.94
  • HMNF $27.06
  • Average True Range (ATR)
  • BCAB 0.16
  • HMNF 0.63
  • MACD
  • BCAB -0.01
  • HMNF -0.07
  • Stochastic Oscillator
  • BCAB 5.66
  • HMNF 24.27

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About HMNF HMN Financial Inc.

HMN Financial Inc is a stock savings bank holding company of Home Federal Savings Bank. The bank is engaged in community banking and operates retail banking and loan production facilities in Minnesota, Iowa, and Wisconsin. It is involved in the business of attracting deposits from the general public and businesses and using such deposits to originate single-family residential, commercial real estate, and multi-family mortgage loans as well as consumer, construction, and commercial business loans. The bank also invests in mortgage-backed and related securities, U.S. government agency obligations, and other permissible investments. Its products and services include checking and savings accounts, cash deposits, online services, and credit cards among others.

Share on Social Networks: